REGULATION OF APOPTOSIS BY NOS
REGULATION OF APOPTOSIS BY NOS
批准号:
2602787
负责人:
JOAN B MANNICK
金额:
$11.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-01 至 2000-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the Investigator's abstract): Nitric oxide (NO)
is a small, highly reactive gas synthesized by the enzyme NO synthase (NOS).
NOS activity in murine leukocytes has been shown to play an important role
in the murine immune response. However, the role of NOS in the human immune
system remains highly controversial because NOS-associated effects in human
leukocytes have been very difficult to demonstrate. Our preliminary data
indicate that very low levels of NOS expressed constitutively in human
lymphocyte or monocyte-derived cells lines regulate apoptosis. We
hypothesize that NOS activity regulates apoptosis in human primary
lymphocytes and/or monocytes as well as in cell lines, and therefore, that
NOS activity has a physiologically relevant role in the human immune system.
In Specific Aim 1, we will test this hypothesis by determining if
NOS-activity in human primary lymphocytes and monocytes regulates
spontaneous or Fas-induce apoptosis. In Specific Aim 2, human lymphocytic
cell lines will be used as models to investigate the mechanism by which NOS
inhibits Fas-induced apoptosis. Our hypothesis is that NOS activity
inhibits Fas-induced apoptosis at the level of Fas-associated protein
complex formation. The proposed studies will contribute ot the immunology
and nitric oxide fields. The studies will clarify whether NOS activity has
a physiologic role in the human as well as the murine immune system: will
provide insight into the mechanism by which NOS activity exerts biological
effects in human cells; and will elucidate a novel NOS-dependent regulation
of Fas-induced apoptosis. Ultimately these studies may lead to the
development of NO-based therapies to treat disorders associated with
dysregulation of apoptosis including autoimmune diseases, cancer and the
acquired immunodeficiency syndrome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pilot study of RTB101 as COVID-19 prophylaxis in older adults with amended research plan and budget
-
批准号:10254578
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2019
-
负责人:JOAN B MANNICK
-
依托单位:
mTOR Regulation of Basal Antiviral Immunity in the Elderly
-
批准号:10474737
-
项目类别:
-
资助金额:$29.24万
-
财政年份:2019
-
负责人:JOAN B MANNICK
-
依托单位:
Pilot study of RTB101 as COVID-19 prophylaxis in older adults
-
批准号:10170919
-
项目类别:
-
资助金额:$65.96万
-
财政年份:2019
-
负责人:JOAN B MANNICK
-
依托单位:
Depletion of Mitochondrial S-Nitrosothiols in ALS
-
批准号:6816525
-
项目类别:
-
资助金额:$22.06万
-
财政年份:2004
-
负责人:JOAN B MANNICK
-
依托单位:
Depletion of Mitochondrial S-Nitrosothiols in ALS
-
批准号:6878138
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2004
-
负责人:JOAN B MANNICK
-
依托单位:
Nitrosylation of Cytochrome C during Apoptosis
-
批准号:6574639
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2003
-
负责人:JOAN B MANNICK
-
依托单位:
Nitrosylation of Cytochrome C during Apoptosis
-
批准号:7011252
-
项目类别:
-
资助金额:$27.17万
-
财政年份:2003
-
负责人:JOAN B MANNICK
-
依托单位:
Nitrosylation of Cytochrome C during Apoptosis
-
批准号:7171573
-
项目类别:
-
资助金额:$26.38万
-
财政年份:2003
-
负责人:JOAN B MANNICK
-
依托单位:
Nitrosylation of Cytochrome C during Apoptosis
-
批准号:6695618
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2003
-
负责人:JOAN B MANNICK
-
依托单位:
Nitrosylation of Cytochrome C during Apoptosis
-
批准号:6847743
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2003
-
负责人:JOAN B MANNICK
-
依托单位:
REGULATION OF APOPTOSIS BY NOS
-
批准号:2900931
-
项目类别:
-
资助金额:$11.76万
-
财政年份:1998
-
负责人:JOAN B MANNICK
-
依托单位:
ROLE OF EBNA-LP IN EBV-INDUCED TRANSFORMATION
-
批准号:3085395
-
项目类别:
-
资助金额:$9.07万
-
财政年份:1990
-
负责人:JOAN B MANNICK
-
依托单位:
ROLE OF EBNA-LP IN EBV-INDUCED TRANSFORMATION
-
批准号:3085394
-
项目类别:
-
资助金额:$9.02万
-
财政年份:1990
-
负责人:JOAN B MANNICK
-
依托单位:
EBNA LP AND EBV INDUCED TRANSFORMATION
-
批准号:2057015
-
项目类别:
-
资助金额:$9.15万
-
财政年份:1990
-
负责人:JOAN B MANNICK
-
依托单位:
ROLE OF EBNA-LP IN EBV-INDUCED TRANSFORMATION
-
批准号:3085393
-
项目类别:
-
资助金额:$9.15万
-
财政年份:1990
-
负责人:JOAN B MANNICK
-
依托单位:
ROLE OF EBNA-LP IN EBV-INDUCED TRANSFORMATION
-
批准号:3085391
-
项目类别:
-
资助金额:$7.72万
-
财政年份:1990
-
负责人:JOAN B MANNICK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: